Published in Pediatr Hematol Oncol on June 16, 2000
Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study. Br J Cancer (2002) 1.14
IGF1 and leukemia. Pediatr Hematol Oncol (2000) 0.80
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses (1995) 2.53
Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J (2002) 2.03
Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? Isr J Med Sci (1966) 2.03
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A (1989) 1.95
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89
Iron overload following bone marrow transplantation in children: MR findings. Pediatr Radiol (1997) 1.63
Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci (1969) 1.54
Ectopic thyroid gland. A clinical study of 30 children and review. J Pediatr (1978) 1.53
Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci (1993) 1.49
Oral clonidine as a growth hormone stimulation test. Lancet (1979) 1.48
Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. Isr Med Assoc J (2000) 1.46
Impact of the Gulf War on the anxiety, cortisol, and growth hormone levels of Israeli civilians. Am J Psychiatry (1994) 1.44
Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab (1971) 1.43
Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol (1997) 1.42
Postnatal changes in some red cell parameters. Acta Paediatr Scand (1971) 1.42
Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy. Surg Clin North Am (2001) 1.41
Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res (2006) 1.41
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40
Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone. J Endocrinol Invest (1992) 1.40
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML. Pediatr Blood Cancer (2006) 1.39
Safety of pituitary growth hormone extracted with acetone/acetic acid. Lancet (1994) 1.38
Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease. Blood Cells Mol Dis (1998) 1.38
Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a) Eur J Endocrinol (1997) 1.38
Perceptions about advance directives by nurses in a community hospital. Clin Nurse Spec (2001) 1.37
Subtotal splenectomy in Gaucher's disease: towards a definition of critical splenic mass. Br J Surg (1992) 1.37
Volvulus of the stomach in childhood: the spectrum of the disease. Pediatr Emerg Care (2001) 1.34
Hepatic iron overload: quantitative MR imaging. Radiology (1991) 1.32
Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci (1984) 1.30
Withdrawal of human pituitary growth hormone. Lancet (1985) 1.30
A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care (1980) 1.23
A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome). J Pediatr (1988) 1.23
Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20
Synovial sarcoma of bone delineated by spectral karyotyping. Lancet (1997) 1.18
Age at first conscious ejaculation: a milestone in male puberty. Helv Paediatr Acta (1980) 1.14
Crisis intervention program in newly diagnosed diabetic children. Diabetes Care (1983) 1.12
A vasopressin analogue in treatment of diabetes insipidus. Arch Dis Child (1974) 1.10
Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) (1980) 1.09
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? Leukemia (2008) 1.08
The impact of long-term therapy by a multidisciplinary team on the education, occupation and marital status of growth hormone deficient patients after termination of therapy. Clin Endocrinol (Oxf) (1987) 1.08
Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer (1983) 1.08
Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood (1996) 1.08
bcr-abl RNA in patients with chronic myelogenous leukemia. Blood (1987) 1.07
The comparative effect of 6 alpha-fluoroprednisolone, 6 alpha-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease. J Pediatr (1968) 1.07
Response of plasma LH and FSH to synthetic LH-RH in children at various pubertal stages. Am J Dis Child (1976) 1.07
Prolactin deficiency, obesity, and enlarged testes--a new syndrome? Arch Dis Child (1980) 1.07
Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer (1980) 1.06
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia (2005) 1.06
Detection of varicella-zoster virus in lymphocytes by DNA hybridization. J Med Virol (1987) 1.04
Is the Laron mouse an accurate model of Laron syndrome? Mol Genet Metab (1999) 1.04
Juvenile hypothyroidism with testicular enlargement. Acta Paediatr Scand (1970) 1.04
Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res (2001) 1.03
The reluctance of house staff to perform mouth-to-mouth resuscitation in the inpatient setting: what are the considerations? Resuscitation (1994) 1.03
D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty. Lancet (1981) 1.03
Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol (1991) 1.03
Bloom's syndrome. VI. The disorder in Israel and an estimation of the gene frequency in the Ashkenazim. Am J Hum Genet (1977) 1.03
A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene (1997) 1.02
Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience. Clin Endocrinol (Oxf) (1984) 1.02
Concentrations of U and Po in animal feed supplements, in poultry meat and in eggs. Health Phys (1989) 1.00
A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008. Diabet Med (2011) 1.00
Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia (2010) 1.00
Partial splenectomy in Gaucher's disease. J Pediatr Surg (1986) 0.99
Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. Oral Surg Oral Med Oral Pathol (1988) 0.98
Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Hum Immunol (1980) 0.98
Paternity in Klinefelter's syndrome--a case report. Arch Androl (1982) 0.98
Human growth hormone gene deletion without antibody formation or growth arrest during treatment--a new disease entity? Isr J Med Sci (1985) 0.98
Eye findings in congenital telangiectatic erythema and growth retardation (Bloom's syndrome). Am J Ophthalmol (1966) 0.98
Hypothalamo-pituitary hormone insufficiency associated with cleft lip and palate. Arch Dis Child (1978) 0.97
Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr J Med Sci (1969) 0.97
Systematic use of automated fluorescence-based sequence analysis of amplified genomic DNA for rapid detection of point mutations. Am J Hematol (1994) 0.96
Insulin response to intravenous glucagon in children with familial constitutional short stature. Arch Dis Child (1975) 0.96
Puberty in Laron type dwarfism. Eur J Pediatr (1980) 0.95
Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab (1996) 0.95
Anal stenosis with megarectum: an unusual complication of a perineal burn. J Burn Care Rehabil (1993) 0.95
Metabolic substrates and hormones during starvation ketosis in children. Am J Clin Nutr (1968) 0.95
Oesophageal plastic repair for symptomatic ballooning following circular oesophageal myotomy and correction of oesophageal atresia. Thorax (1997) 0.95
Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone. Isr J Med Sci (1969) 0.94
Pituitary growth hormone insufficiency associated with cleft lip and palate. An embryonal developmental defect. Helv Paediatr Acta (1969) 0.94
Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone--a Roentgenologic study. Horm Metab Res (1972) 0.93
Central nervous system involvement in children with sarcoma. Oncology (2003) 0.93
Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol (2000) 0.93
Putting a lid on injury costs: the economic impact of the California motorcycle helmet law. J Trauma (1998) 0.92
Evaluation of testicular function in prepubertal boys by means of the luteinizing hormone-releasing hormone test. Fertil Steril (1978) 0.92
Lack of seasonality in the month of onset of childhood IDDM (0.7-15 years) in Shanghai, China. J Pediatr Endocrinol Metab (1998) 0.92
Residual B cell function in diabetic children as determined by urinary C-peptide. Diabetologia (1983) 0.92
Penis and testicular size in patients with growth hormone insufficency. Acta Endocrinol (Copenh) (1970) 0.92
Hyperprolactinaemia in a boy with hypothyroidism due to an ectopic thyroid. Acta Paediatr Belg (1978) 0.92
Premature thelarche--natural history and sex hormone secretion in 68 girls. Acta Paediatr Scand (1984) 0.91
Wolfram syndrome. Am J Dis Child (1978) 0.91
Osteosynthesis of the injured chest wall. Use of the AO (Arbeitsgemeinschaft für Osteosynthese) technique. Scand J Thorac Cardiovasc Surg (1993) 0.91
Beta-endorphins in acute myocardial infarction. Clin Cardiol (1986) 0.91
Metastatic brain involvement in Ewing family of tumors in children. Neurology (1998) 0.91